Opthea

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Opthea and buy or sell other stocks, ETFs, and their options commission-free!

About OPTEY

Opthea Ltd. is a clinical stage biopharmaceutical company, which engages in the development and research of novel therapeutic products based on targeting Vascular Endothelial Growth Factors. It operates through the United States and Australia geographical segments. 

CEO
Jeremy Max Levin
CEOJeremy Max Levin
Employees
Employees
Headquarters
Melbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded
1984
Founded1984
Employees
Employees

OPTEY Key Statistics

Market cap
631.92M
Market cap631.92M
Price-Earnings ratio
0.02
Price-Earnings ratio0.02
Dividend yield
Dividend yield
Average volume
2.93K
Average volume2.93K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$3.17
52 Week high$3.17
52 Week low
$0.0059
52 Week low$0.0059

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.